(Q37067896)

18 August 2017

The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa (English)

1 reference

18 August 2017

0 references

1 reference

parkinsonian syndrome

1 reference

1

G Curzon

1 reference

18 August 2017

PMCID

493400

Richard B. Godwin-Austen

series ordinal

2

object named as

R B Godwin-Austen

1 reference

18 August 2017

3

E B Tomlinson

1 reference

18 August 2017

4

B D Kantamaneni

1 reference

18 August 2017

PMCID

493400

language of work or name

English

0 references

publication date

1 February 1970

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

18 August 2017

1 reference

18 August 2017

33

1 reference

18 August 2017

1

1 reference

18 August 2017

1-6

1 reference

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

The brain-stem lesions in Parkinsonism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

Acceleration of the cerebral dopamine turnover by chlorpromazine

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

L-dopa in postencephalitic parkinsonism.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

Modification of Parkinsonism--chronic treatment with L-dopa

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

Chemical and physiological changes produced by arterial infusion of dihydroxyphenylalanine into one cerebral hemisphere of the cat

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493400

L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism

4 September 2018

1 reference

12 December 2020

[The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease.]

1 reference

12 December 2020

Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism

1 reference

12 December 2020

1 reference

12 December 2020

Effects of L-dopa in Parkinson's disease.

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.33.1.1

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

493400